Primary treatment of multiple myeloma with thalidomide, vincristine, liposomal doxorubicin and dexamethasone(T-VAD doxil): a phase II multicenter study

Konstantinos Zervas; Meletios A Dimopoulos; E Hatzicharissi; Αchilles Anagnostopoulos; Mary Papaioannou; C. Mitsouli; P. Panagiotidis; John Korantzis; M. Tzilianos; Alice Maniatis

doi:10.1093/annonc/mdh026

Related publications

Article2007

VAD-doxil versus VAD-doxil plus thalidomide as initial treatment for multiple myeloma: results of a multicenter randomized trial of the Greek myeloma study group

Konstantinos Zervas, Dimitra Mihou, Eirini Katodritou, Anastasia Pouli, C. Mitsouli, Αchilles Anagnostopoulos, Souzana Delibasi, Maria‐Christina Kyrtsonis, Nicolaos Anagnostopoulos, Evangelos Terpos, Panagiotis Zikos, Alice Maniatis, Meletios A Dimopoulos

Article2006

VAD-doxil vs.VAD-doxil Plus Thalidomide as Initial Treatment in Patients with Multiple Myeloma: A Multicenter Randomized Trial of the Greek Myeloma Study Group.

Konstantinos Zervas, Dimitra Mihou, Irini Katodritou, Anastasia Pouli, Chrisanthi Mitsouli, Αchilles Anagnostopoulos, Souzana Delimbasi, Marie‐Christine Kyrtsonis, Nikolaos Anagnostopoulos, Evangelos Terpos, Panagiotis Zikos, Meletios A Dimopoulos

Article2006

Primary treatment with pulsed melphalan, dexamethasone and thalidomide for elderly symptomatic patients with multiple myeloma.

Meletios A Dimopoulos, Αchilles Anagnostopoulos, Evangelos Terpos, Panagiotis Repoussis, Athanasios Zomas, Eirini Katodritou, Marie Christine Kyrtsonis, Souzana Delibasi, Amalia Vassou, Anastasia Pouli, Konstantinos Zervas, Nikolaos Anagnostopoulos, Alice Maniatis

Article1992

Primary dexamethasone treatment of multiple myeloma

Raymond Alexanian, Meletios A Dimopoulos, Kay Delasalle, B Barlogie

Article1992

Primary dexamethasone treatment of multiple myeloma

R Alexanian, Meletios A Dimopoulos, Kay Delasalle, Bart Barlogie

Primary treatment of multiple myeloma with thalidomide, vincristine, liposomal doxorubicin and dexamethasone(T-VAD doxil): a phase II multicenter study

Discussion(0)

Related publications

VAD-doxil versus VAD-doxil plus thalidomide as initial treatment for multiple myeloma: results of a multicenter randomized trial of the Greek myeloma study group

VAD-doxil vs.VAD-doxil Plus Thalidomide as Initial Treatment in Patients with Multiple Myeloma: A Multicenter Randomized Trial of the Greek Myeloma Study Group.

Primary treatment with pulsed melphalan, dexamethasone and thalidomide for elderly symptomatic patients with multiple myeloma.

Primary dexamethasone treatment of multiple myeloma

Primary dexamethasone treatment of multiple myeloma